IOVANCE BIOTHERAPEUTICS, INC. Gain (Loss) Related to Litigation Settlement
IOVANCE BIOTHERAPEUTICS, INC. (IOVA) reported Gain (Loss) Related to Litigation Settlement of $336.00 thousand for the 12-month period ending 2019-12-31, per its 10-K filed 2022-02-24.
Discontinued › Income Statement › Other Income
us-gaap:GainLossRelatedToLitigationSettlement · last filed 2022-02-24
- IOVANCE BIOTHERAPEUTICS, INC. gain (loss) related to litigation settlement for the quarter ending 2019-12-31 was $0.00.
- IOVANCE BIOTHERAPEUTICS, INC. gain (loss) related to litigation settlement for the quarter ending 2019-09-30 was $0.00.
- IOVANCE BIOTHERAPEUTICS, INC. gain (loss) related to litigation settlement for the quarter ending 2019-06-30 was $0.00.
- IOVANCE BIOTHERAPEUTICS, INC. gain (loss) related to litigation settlement for the quarter ending 2019-03-31 was $336.00K.
- IOVANCE BIOTHERAPEUTICS, INC. gain (loss) related to litigation settlement for fiscal 2019 was $336.00K.
| Period end | Gain (Loss) Related to Litigation Settlement 3 month | Gain (Loss) Related to Litigation Settlement 3 month as first filed | Gain (Loss) Related to Litigation Settlement 6 month | Gain (Loss) Related to Litigation Settlement 9 month | Gain (Loss) Related to Litigation Settlement 12 month |
|---|---|---|---|---|---|
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $0.00 derived: sum of 2 quarters · filed 2022-02-24 | $0.00 derived: sum of 3 quarters · filed 2022-02-24 | $336.00K 10-K · filed 2022-02-24 | |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $0.00 derived: sum of 2 quarters · filed 2020-11-05 | $336.00K 10-Q · filed 2020-11-05 | ||
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $336.00K 10-Q · filed 2020-08-06 | |||
| 2019-03-31 | $336.00K 10-Q · filed 2020-05-05 | $335.00K 10-Q · filed 2019-05-07 | |||
| 2018-03-31 | $0.00 10-Q · filed 2019-05-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Adaptive Biotechnologies Corp (ADPT) | United States | $4.719B | -53.43 |
| CRISPR Therapeutics AG (CRSP) | $5.390B | -11.68 | |
| Relay Therapeutics, Inc. (RLAY) | United States | $3.884B | -14.30 |
| Scholar Rock Holding Corp (SRRK) | United States | $5.920B | -16.37 |
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |
| Tarsus Pharmaceuticals, Inc. (TARS) | United States | $3.329B | -58.60 |
| Denali Therapeutics Inc. (DNLI) | United States | $3.274B | -8.04 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Greenland Mines Ltd (GRML) | United States | $2.362B |